Functional properties of Lactobacillus strains isolated from dairy products

被引:0
作者
Dobroslava Bujňáková
Vladimír Kmeť
机构
[1] Institute of Animal Physiology,
[2] Slovak Academy of Sciences,undefined
来源
Folia Microbiologica | 2012年 / 57卷
关键词
Lactobacillus; Lactobacillus Strain; Lactose Intolerance; Dalfopristin; Intestinal Pathogen;
D O I
暂无
中图分类号
学科分类号
摘要
Twenty-four acid- and bile-tolerant lactobacilli isolates from dairy products were identified and further in vitro characterized for the presence of functional traits potentially useful for probiotic applications, which included desirable and undesirable traits, such as biofilm formation, ability to inhibit intestinal pathogens, antibiotic susceptibility, and enzyme activity. The majority of examined strains were susceptible to certain antimicrobial agents (streptomycin, gentamicin, clindamycin, erythromycin, tetracycline, quinupristin–dalfopristin), except for three strains of Lactobacillus rhamnosus with minimal inhibitory concentration levels for streptomycin higher than the microbiological breakpoints (≥32 μg/mL), which are considered as resistant. Undesirable traits such as α-chymotrypsin or N-acetyl-β-glucosaminidase activities were not detected, but low β-glucuronidase, and moderate and high β-glucosidase activities were recorded in nine strains, which were eliminated from further examination together with three isolates showing unsuitable antibiotic resistance. Of the remaining 12 isolates, 4 (Lactobacillus fermentum 202, Lactobacillus gallinarum 7001, L. rhamnosus 183, and Lactobacillus plantarum L2-1) manifested an outstanding potential to inhibit selected intestinal pathogens in an agar spot test, including Escherichia coli and Salmonella spp., and simultaneously demonstrated strong biofilm-forming capacity. In conclusion, the results of our in vitro experiments showed that the above four strains had a potential probiotic value and met the criteria to be identified as a possible probiotic microorganism, with the necessity of verification through well-designed in vivo experimental, clinical, and technological studies before the strains can be used as probiotics or as starter probiotic cultures.
引用
收藏
页码:263 / 267
页数:4
相关论文
共 77 条
[1]  
Ambadoyiannis G(2005)Probiotic and technological properties of enterococci isolates from infants and cheese Food Biotechnol 18 307-325
[2]  
Hatzikamari M(1990)Characteristics of enzyme profiles of J Dairy Sci 73 264-273
[3]  
Litopoulou-Tzanetaki E(2005) species by a rapid API–ZYM system LWT- Food Sci Technol 38 691-694
[4]  
Tzanetakis N(1997)Determination of the bacteriocin-like substances produced by some lactic acid bacteria isolated from Turkish dairy products Appl Environ Microbiol 63 2747-2753
[5]  
Arora G(2011)The human Clin Microbiol Infect 17 533-538
[6]  
Lee BH(2001) strain LA1 secretes a non-bacteriocin antibacterial substance(s) active Am J Clin Nutr 73 386S-392S
[7]  
Lamoureux M(2004) and Best Pract Res Clin Gastroenterol 18 323-336
[8]  
Aslim B(2008)Matrix-assisted laser-desorption/ionization Pak J Bot 40 867-875
[9]  
Yuksekdag ZN(1999): experience in the routine of a University hospital Appl Environ Microbiol 65 4949-4956
[10]  
Sarikaya E(2006) selection criteria for probiotic bacteria of human origin: correlation with Folia Microbiol 53 189-194